276
Participants
Start Date
February 29, 2008
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
Niacin extended-release (NER)
Tablets administered once daily for 6 weeks; titrated to a maximum dose of 2000 mg
Niacin extended-release (NER) placebo
Tablets administered once daily for 6 weeks
Aspirin (ASA)
Tablets (325 mg) administered once daily for 6 weeks
Aspirin (ASA) placebo
Tablets administered once daily for 6 weeks
Pittsburgh
Duncansville
Harleysville
High Point
Durham
Salisbury
Statesville
Greer
Daytona Beach
Jacksonville
Hollywood
Pembroke Pines
Miami
Largo
Brooksville
Birmingham
Cincinnati
Menomonee Falls
Milwaukee
Chicago
St Louis
Topeka
Arkansas City
Wichita
Wichita
Carrollton
Dallas
San Antonio
San Antonio
Austin
Denver
Boise
Magna
Sandy City
Murray
Las Vegas
Anaheim
Walnut Creek
Portland
Gig Harbor
Lead Sponsor
Abbott
INDUSTRY